Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort

Abstract

Aim

To evaluate the factors associated with changes in self-efficacy in systemic lupus erythematosus (SLE) patients from a prevalent cohort.

Methods

Members of the Almenara Lupus Cohort who had entered it between 2018 and 2024 were included. Sociodemographic variables were collected. Self-efficacy was examined with the five domains of the PROMIS self-efficacy for the management of chronic conditions’ instrument and general self-efficacy. The Short Form (SF)-36 health questionnaire’ [physical and mental component summary measures (PCS and MCS)] was obtained. Disease activity was ascertained with the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and damage with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Therapeutic variables included the use of antimalarials and of immunosuppressants as well as the daily prednisone dose. Generalized estimating equations were performed using general self-efficacy and the five domains for chronic disease management as outcomes.

Results

331 patients were included; their mean age at diagnosis was 35.1 (SD = 13.7) years and 91.5% their disease duration at baseline was 10.3 (SD = 7.49) years; (n = 303) were women; 97.9% were Mestizo. Factors associated with a better general self-efficacy were White ethnicity (β = 7.09, SE = 1.14, p < 0.001), being currently employed (β = 1.09, SE = 0.53, p = 0.038), PCS (β = 0.08, SE = 0.02, p < 0.001), and previous general self-efficacy (β = 0.39, SE = 0.05, p < 0.001). In contrast, Black ethnicity (β = −2.06, SE = 0.56, p < 0.001 and daily prednisone dose (β = −0.13, SE = 0.02, p < 0.001) were negatively associated with general self-efficacy.

Conclusions

Factors associated with general self-efficacy improvement were higher previous self-efficacy, White ethnicity, being currently employed and having a better HRQoL In contrast, Black ethnicity and higher daily prednisone dose predisposed to general self-efficacy worsening.

Keywords

self-efficacy systemic lupus erythematosus mental health

Get full access to this article

View all access options for this article.

References

Ameer

Chaudhry

Mushtaq

, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus 2022; 14: e30330. https://doi.org/10.7759/cureus.30330

Elefante

Cornet

Andersen

, et al. The communication GAP between patients and clinicians and the importance of patient reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2023; 37: 101939. https://doi.org/10.1016/j.berh.2024.101939

Drenkard

Easley

Bao

, et al. Cross-sectional study of the effects of self-efficacy on fatigue and pain interference in black women with systemic lupus erythematosus: the role of depression, age and education. Lupus Sci Med 2022; 9: e000566. https://doi.org/10.1136/lupus-2021-000566

Somers

Kurakula

Criscione-Schreiber

, et al. Self-efficacy and pain catastrophizing in systemic lupus erythematosus: relationship to pain, stiffness, fatigue, and psychological distress. Arthritis Care Res 2012; 64: 1334–1340. https://doi.org/10.1002/acr.21686

Falasinnu

Bao

Brady

, et al. Factors associated with the initiation and retention of patients with lupus in the chronic disease self-management program. Arthritis Care Res 2023; 75: 519–528. https://doi.org/10.1002/acr.24811

Chan

SW-C

. Chronic disease management, self-efficacy and quality of life. J Nurs Res 2021; 29: e129. https://doi.org/10.1097/JNR.0000000000000422

Farley

. Promoting self-efficacy in patients with chronic disease beyond traditional education: a literature review. Nurs Open 2020; 7: 30–41. https://doi.org/10.1002/nop2.382

Kerari

Bahari

Alharbi

, et al. The effectiveness of the chronic disease self-management program in improving patients’ self-efficacy and health-related behaviors: a quasi-experimental study. Healthcare (Basel) 2024; 12: 778. https://doi.org/10.3390/healthcare12070778

Ugarte-Gil

Gamboa-Cardenas

Reátegui-Sokolova

, et al. A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara lupus cohort. Lupus Sci Med 2023; 10: e000874. https://doi.org/10.1136/lupus-2022-000874

10.

Bonsaksen

Lerdal

Fagermoen

. Factors associated with self-efficacy in persons with chronic illness. Scand J Psychol 2012; 53: 333–339. https://doi.org/10.1111/j.1467-9450.2012.00959.x

11.

Shakya

. Self-efficacy among patients with chronic diseases and its associated factors. J Kathmandu Med Coll 2018; 7: 82–88. https://doi.org/10.3126/jkmc.v7i3.22675

12.

Oluma

Abadiga

Mosisa

, et al. Perceived self-efficacy and associated factors among adult patients with type 2 diabetes mellitus at public hospitals of western Ethiopia, 2020. Patient Prefer Adherence 2020; 14: 1689–1698. https://doi.org/10.2147/PPA.S275887

13.

Lai

P-C

S-FV

Alizargar

, et al. Factors influencing self-efficacy and self-management among patients with pre-end-stage renal disease (pre-ESRD). Healthcare (Basel) 2021; 9: 266. https://doi.org/10.3390/healthcare9030266

14.

Ugarte-Gil

Gamboa-Cárdenas

Zevallos

, et al. High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients. Lupus 2014; 23: 969–974. https://doi.org/10.1177/0961203314531083

15.

Hochberg

. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40(9): 1725. https://doi.org/10.1002/art.1780400928

16.

Petri

Orbai

Alarcon

, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64(8): 2677–2686. https://doi.org/10.1002/art.34473

17.

Charlson

Pompei

Ales

, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373–383. https://doi.org/10.1016/0021-9681(87)90171-8

18.

Gladman

Ibañez

Urowitz

. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–291.

19.

Gladman

Ginzler

Goldsmith

, et al. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369. https://doi.org/10.1002/art.1780390303

20.

Ware

JEJ

Sherbourne

. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.

21.

Gruber-Baldini

Velozo

Romero

, et al. Validation of the PROMIS® measures of self-efficacy for managing chronic conditions. Qual Life Res 2017; 26: 1915–1924. https://doi.org/10.1007/s11136-017-1527-3

22.

Salsman

Schalet

Merluzzi

, et al. Calibration and initial validation of a general self-efficacy item bank and short form for the NIH PROMIS®. Qual Life Res 2019; 28: 2513–2523. https://doi.org/10.1007/s11136-019-02198-6

23.

Cross

March

Lapsley

, et al. Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure. Rheumatology (Oxford) 2006; 45: 92–96. https://doi.org/10.1093/rheumatology/kei114

24.

Hoge

Bowling

Lim

, et al. Association of poverty income ratio with physical functioning in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2020; 47: 983–990. https://doi.org/10.3899/jrheum.190991

25.

Williams

Drenkard

Lim

. The impact of social determinants of health on the presentation, management and outcomes of systemic lupus erythematosus. Rheumatology (Oxford) 2023; 62: i10–i14. https://doi.org/10.1093/rheumatology/keac613

26.

Oliveira-Santos

Verani

Klumb

, et al. Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil. Lupus 2011; 20: 320–329. https://doi.org/10.1177/0961203310383736

27.

Ren

Zhu

Lin

, et al. Exploring the mechanism of self-management: the role of social support, self-efficacy, and health literacy based on meta-analytic structural equation modeling. BMC Public Health 2025; 26(1): 128. https://doi.org/10.1186/s12889-025-24860-0

28.

Staszkiewicz

Kulesa-Mrowiecka

Szklarczyk

, et al. Life satisfaction, generalized sense of self-efficacy and acceptance of illness in rheumatoid arthritis patients depending on age and severity of the disease. Reumatologia 2023; 61(3): 175–185. https://doi.org/10.5114/reum/168294

29.

Tong

XZM

Sun

, et al. The serial mediating role of self-esteem and health literacy in the relationship between self-efficacy and benefit finding among Chinese systemic lupus erythematosus patients. Front Psychol 2026; 17: 1784999. https://doi.org/10.3389/fpsyg.2026.1784999

30.

Martin-Iglesias

Paredes-Ruiz

Ruiz-Irastorza

. Use of glucocorticoids in SLE: a clinical approach. Mediterr J Rheumatol 2024; 35: 342–353. https://doi.org/10.31138/mjr.230124.uos

31.

Mak

Isenberg

Lau

. Global trends, potential mechanisms and early detection of organ damage in SLE. Nat Rev Rheumatol 2013; 9: 301–310. https://doi.org/10.1038/nrrheum.2012.208

32.

Ugarte-Gil

Mak

Leong

, et al. Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis. Lupus Sci Med 2021; 8: e000590. https://doi.org/10.1136/lupus-2021-000590

33.

Bruce

O’Keeffe

Farewell

, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the systemic lupus international collaborating clinics (SLICC) inception cohort. Ann Rheum Dis 2015; 74(9): 1706–1713. https://doi.org/10.1136/annrheumdis-2013-205171

34.

Segura

Bernstein

McDonnell

, et al. Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort. Rheumatology (Oxford) 2020; 59(3): 524–533. https://doi.org/10.1093/rheumatology/kez292

35.

Hall

. Illness perceptions and self-efficacy in African American women diagnosed with systemic lupus erythematosus [dissertation]. The University of Texas Medical Branch, 2020.

36.

Gavilán-Carrera

Garcia da Silva

Vargas-Hitos

, et al. Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity. PLoS One 2019; 14(2): e0212436. https://doi.org/10.1371/journal.pone.0212436

37.

Liu

Jia

Wang

, et al. Mental health conditions in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Rheumatology (Oxford) 2024; 63(12): 3234–3242. https://doi.org/10.1093/rheumatology/keae239

38.

Luo

Zhong

Zheng

, et al. Influence of social support on subjective well-being of patients with chronic diseases in China: chain-mediating effect of self-efficacy and perceived stress. Front Public Health 2023; 11: 1184711. https://doi.org/10.3389/fpubh.2023.1184711

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.42 MB